Targeting ALG3/FOXD1/BNIP3 Axis Prevents Mitophagy and Gemcitabine Resistance of Nasopharyngeal Carcinoma
Year: 2025
Type: article
Abstract: -glycosylation. Targeting the ALG3/FOXD1/BNIP3 axis offers a promising therapeutic strategy to inhibit the progression of NPC, which highlighting the potential of therapeutics targeting ALG3 and FOXD1 for regulating mitophagy and overcoming GEM resistance.
DOI: 10.7150/ijbs.101585
Authors: Zhanwang Wang, Yi Jin, Dong He, Yuxing Zhu, Mengqing Xiao, Xiaoming Liu, Yaxin Cheng, Ke Cao
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,337
OpenAlex ID: W4407776359